Finasteride – Teva Pharmaceutical Teva Pharmaceutical — Research Summary
Finasteride is a 5α-reductase type II inhibitor pharmaceutical manufactured by Teva Pharmaceuticals, representing a benchmark compound in androgenic hormone research. This synthetic azasteroid selectively inhibits the enzyme responsible for converting testosterone to dihydrotestosterone (DHT) in tissue-specific research models. Originally developed as a pharmaceutical intervention, finasteride has become a critical reference standard for researchers investigating DHT-mediated pathways and androgenic signalling mechanisms. Research scientists at Stroid UK Shop frequently utilise this compound to study hormone modulation effects in controlled laboratory environments.
Laboratory Applications
In research settings, finasteride enables detailed investigation of 5α-reductase enzymatic pathways and their downstream effects on androgenic tissue responses. Studies have examined its mechanism of competitive inhibition at the enzyme active site, reducing DHT formation by approximately 70% in tissue culture models. Researchers investigating prostate tissue biology, hair follicle development, and sebaceous gland function often incorporate finasteride as a control compound. The pharmaceutical-grade preparation from Teva ensures consistent results across experimental protocols. Comparative studies frequently examine finasteride alongside compounds from our aromatase inhibitor collection to distinguish between different hormonal pathway interventions. Metabolic researchers also investigate interactions with selective androgen receptor modulators and peptide compounds to understand complex endocrine signalling networks.
Chemical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | N-(2-Methyl-2-propyl)-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide |
| CAS Number | 98319-26-7 |
| Molecular Formula | C₂₃H₃₆N₂O₂ |
| Molecular Weight | 372.55 g/mol |
| Manufacturer | Teva Pharmaceuticals |
| Purity | Pharmaceutical grade |
| Storage | Room temperature, dry environment |
| Solubility | DMSO, ethanol, limited water solubility |
Research Compliance
This finasteride preparation is manufactured to pharmaceutical standards by Teva and supplied exclusively for in-vitro laboratory research applications. Researchers must ensure appropriate safety protocols and institutional oversight when handling this compound. All studies should follow established guidelines for androgenic hormone research and maintain proper documentation for regulatory compliance. This product is intended solely for scientific investigation and analytical purposes in accredited research facilities. Not approved for human consumption or therapeutic applications.
